Edition:
United States

People: Roche Holding AG (ROG.S)

ROG.S on Virt-X Level 1

278.70CHF
8:40am EDT
Change (% chg)

CHF3.40 (+1.24%)
Prev Close
CHF275.30
Open
CHF274.60
Day's High
CHF278.90
Day's Low
CHF274.60
Volume
421,512
Avg. Vol
1,606,132
52-wk High
CHF280.55
52-wk Low
CHF209.00

Bell, John 

Prof. John Irving Bell has served as Non-Executive Independent Director of Roche Holding Ltd since 2001. In addition, he acts as Member of the Audit Committee of the Company. In 1975, he gained a Bachelor of Medical Science with Honors from the University of Alberta. In 1976, Prof. Sir Bell gained a Bachelor of Arts with Honors in Physiological Sciences from Magdalen College, Oxford University. In 1979, he gained a Bachelor of Medicine and Bachelor of Surgery (BM, BCh) from Magdalen College, Oxford University. In 1990, he gained a Doctor of Medicine (DM) from Magdalen College, Oxford University. From 1979 until 1982, he carried out postgraduate clinical training in Oxford and London. From 1982 until 1987, Prof. Sir Bell was Clinical Fellow in the Department of Medicine at Stanford University and also Postdoctoral Fellow in the Department of Medical Microbiology at Stanford University. From 1987 until 1989, he was Wellcome Senior Clinical Fellow and Honorary Consultant Physician in the Nuffield Departments of Clinical Medicine and Surgery at John Radcliffe Hospital, Oxford. From 1989 until 1992, he was University Lecturer at the Nuffield Department of Clinical Medicine at Oxford University. From 1992 until 2002, he was Nuffield Professor of Clinical Medicine at Oxford University. Since 2002, Prof. Bell has been Regius Professor of Medicine at Oxford University. He has also been Honorary Consultant Physician at Oxford Radcliffe NHS Trust since 1987; Nuffield Professor of Clinical Medicine Chairman at the Department of Medicine, Oxford University School of Medicine, since 1992; Founder of the Wellcome Trust Centre for Human Genetics since 1993; Chairman of the Partnership Board at the Oxford Centre for Diabetes, Endocrinology and Metabolism since 1999; Chairman of the Trials and Epidemiology Building, Oxford since 1999; and President of the Academy of Medical Sciences since 2006. He was knighted in the 2008 Honors list for Services to Medicine.

Basic Compensation

Total Annual Compensation, CHF 330,000
Restricted Stock Awards, CHF --
Long-Term Incentive Plans, CHF --
All Other, CHF --
Fiscal Year Total, CHF 330,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Severin Schwan

11,760,500

Christoph Franz

5,745,700

Fritz Gerber

--

Andre Hoffmann

439,123

Alan Hippe

5,681,190

Cristina Wilbur

3,717,860
As Of  30 Dec 2018